Brandon Luber

29.8k total citations · 5 hit papers
40 papers, 4.5k citations indexed

About

Brandon Luber is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Brandon Luber has authored 40 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Brandon Luber's work include Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Brandon Luber is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Brandon Luber collaborates with scholars based in United States, Japan and France. Brandon Luber's co-authors include Hao Wang, Bert Vogelstein, Emmanuel S. Antonarakis, Robert A. Anders, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, Franck Housseau, Hongni Fan and Ada Tam and has published in prestigious journals such as Science, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Brandon Luber

40 papers receiving 4.5k citations

Hit Papers

The Vigorous Immune Microenvironment of Microsatellite In... 2014 2026 2018 2022 2014 2016 2015 2017 2015 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
    2014 1.1k citations Nicolás J. Llosa, Michael Cruise et al. Cancer Discovery profile →
  2. Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells
    2016 470 citations Kaitlyn Sadtler, Brian W. Allen et al. Science profile →
  3. Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
    2015 466 citations Emmanuel S. Antonarakis, Changxue Lu et al. profile →
  4. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
    2017 340 citations Emmanuel S. Antonarakis, Changxue Lu et al. Journal of Clinical Oncology profile →
  5. PD-1 blockade in tumors with mismatch repair deficiency.
    2015 339 citations Dung T. Le, Hao Wang et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brandon Luber United States 24 2.5k 1.8k 1.2k 961 774 40 4.5k
Chang Ohk Sung South Korea 33 1.8k 0.7× 838 0.5× 850 0.7× 1.4k 1.5× 522 0.7× 142 4.0k
Takahiro Hasebe Japan 40 2.5k 1.0× 944 0.5× 1.4k 1.1× 1.4k 1.4× 1.0k 1.3× 173 4.8k
Kristen N. Ganjoo United States 35 2.0k 0.8× 3.3k 1.8× 588 0.5× 755 0.8× 1.0k 1.3× 172 5.3k
Brooke E. Howitt United States 45 2.1k 0.8× 1.2k 0.6× 1.1k 0.9× 1.6k 1.7× 1.0k 1.3× 156 6.7k
Lyudmila Bazhenova United States 38 4.5k 1.8× 3.8k 2.1× 2.1k 1.7× 2.0k 2.1× 678 0.9× 169 7.1k
Christina S. Kong United States 35 1.6k 0.6× 737 0.4× 731 0.6× 1.3k 1.4× 341 0.4× 124 4.3k
Gerhard G. Grabenbauer Germany 42 3.1k 1.2× 2.0k 1.1× 812 0.7× 1.0k 1.1× 379 0.5× 179 6.8k
Ashley Cimino‐Mathews United States 37 2.2k 0.9× 907 0.5× 922 0.7× 924 1.0× 655 0.8× 122 3.8k
Alexander Quaas Germany 36 2.1k 0.8× 1.2k 0.7× 628 0.5× 1.1k 1.2× 352 0.5× 227 4.8k

Countries citing papers authored by Brandon Luber

Since Specialization
Citations

This map shows the geographic impact of Brandon Luber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Luber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Luber more than expected).

Fields of papers citing papers by Brandon Luber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Luber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Luber. The network helps show where Brandon Luber may publish in the future.

Co-authorship network of co-authors of Brandon Luber

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Luber. A scholar is included among the top collaborators of Brandon Luber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Luber. Brandon Luber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tieu, Alan H., et al.. (2020). Risk Factors for Progression of Barrett’s Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma. Scientific Reports. 10(1). 4899–4899. 46 indexed citations
2.
Llosa, Nicolás J., Brandon Luber, Nicholas Siegel, et al.. (2019). Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy. Cancer Immunology Research. 7(10). 1574–1579. 32 indexed citations
3.
Antonarakis, Emmanuel S., Changxue Lu, Brandon Luber, et al.. (2018). Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide. European Urology. 74(2). 218–225. 132 indexed citations
4.
Rowe, Steven P., Brandon Luber, Megan D. Schollenberger, et al.. (2018). From validity to clinical utility: the influence of circulating tumorDNAon melanoma patient management in a real‐world setting. Molecular Oncology. 12(10). 1661–1672. 26 indexed citations
5.
O, Joo Hyun, Heather A. Jacene, Brandon Luber, et al.. (2017). Quantitation of Cancer Treatment Response by 18F-FDG PET/CT: Multicenter Assessment of Measurement Variability. Journal of Nuclear Medicine. 58(9). 1429–1434. 12 indexed citations
6.
Teply, Benjamin A., Hao Wang, Brandon Luber, et al.. (2017). Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study. The Lancet Oncology. 19(1). 76–86. 137 indexed citations
7.
Llosa, Nicolás J., Kenneth R. Cooke, Allen Chen, et al.. (2017). Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients. Biology of Blood and Marrow Transplantation. 23(12). 2127–2136. 17 indexed citations
8.
Boudadi, Karim, Daniel L. Suzman, Brandon Luber, et al.. (2017). Phase 2 biomarker-driven study of ipilimumab plus nivolumab (Ipi/Nivo) for ARV7-positive metastatic castrate-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(15_suppl). 5035–5035. 24 indexed citations
9.
10.
11.
Maughan, Benjamin L., Daniel L. Suzman, Brandon Luber, et al.. (2016). Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer. Cancer Chemotherapy and Pharmacology. 78(6). 1297–1304. 21 indexed citations
12.
Sadtler, Kaitlyn, Brian W. Allen, Matthew T. Wolf, et al.. (2016). Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells. Science. 352(6283). 366–370. 470 indexed citations breakdown →
13.
Gunn, Andrew J., et al.. (2016). Predicting Outcomes After Chemo-Embolization in Patients with Advanced-Stage Hepatocellular Carcinoma: An Evaluation of Different Radiologic Response Criteria. CardioVascular and Interventional Radiology. 40(1). 61–68. 4 indexed citations
14.
Wang, Jingya, Amol Narang, Elizabeth A. Sugar, et al.. (2015). Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience. Annals of Surgical Oncology. 22(S3). 1100–1106. 27 indexed citations
15.
Lipson, Evan J., William H. Sharfman, Shuming Chen, et al.. (2015). Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting. Journal of Translational Medicine. 13(1). 214–214. 73 indexed citations
16.
Rodić, Nemanja, Robert A. Anders, James R. Eshleman, et al.. (2014). PD-L1 Expression in Melanocytic Lesions Does Not Correlate with the BRAF V600E Mutation. Cancer Immunology Research. 3(2). 110–115. 42 indexed citations
17.
Llosa, Nicolás J., Michael Cruise, Ada Tam, et al.. (2014). The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints. Cancer Discovery. 5(1). 43–51. 1112 indexed citations breakdown →
18.
Antonarakis, Emmanuel S., Changxue Lu, Brandon Luber, et al.. (2014). Ar-V7 Splice Variant and Resistance to Enzalutamide and Abiraterone in Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc): Overall Survival Results. Annals of Oncology. 25. v1–v1. 2 indexed citations
19.
Suzman, Daniel L., Brandon Luber, Michael T. Schweizer, Rosa Nadal, & Emmanuel S. Antonarakis. (2014). Clinical activity of enzalutamide versus docetaxel in men with castration‐resistant prostate cancer progressing after abiraterone. The Prostate. 74(13). 1278–1285. 79 indexed citations
20.
Antonarakis, Emmanuel S., Changxue Lu, Hao Wang, et al.. (2014). Androgen receptor splice variant, AR-V7, and resistance to enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 32(15_suppl). 5001–5001. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang Ohk Sung Breakdown of academic impact, for papers by Takahiro Hasebe Breakdown of academic impact, for papers by Kristen N. Ganjoo Breakdown of academic impact, for papers by Brooke E. Howitt Breakdown of academic impact, for papers by Lyudmila Bazhenova Breakdown of academic impact, for papers by Christina S. Kong Breakdown of academic impact, for papers by Gerhard G. Grabenbauer Breakdown of academic impact, for papers by Ashley Cimino‐Mathews Breakdown of academic impact, for papers by Alexander Quaas
Rankless by CCL
2026